J&J Offloads LifeScan To Private Equity Firm For $2.1bn

 
• By Reed Miller
  
Business decline
J&J's divestment of LifeScan is part of its overall plan to get out of the diabetes device business. • Source: shutterstock.com
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Deals

More from Business